Results 1 to 10 of about 149,978 (325)
Revisiting mutational resistance to ampicillin and cefotaxime in Haemophilus influenzae [PDF]
Genome MedicineBackground Haemophilus influenzae is an opportunistic bacterial pathogen that can cause severe respiratory tract and invasive infections. The emergence of β-lactamase-negative ampicillin-resistant (BLNAR) strains and unclear correlations between ...
Margo Diricks +13 more
doaj +2 more sources
Haemophilus influenzae tenosynovitis. [PDF]
Annals of the Rheumatic Diseases, 1979 A case is reported of polytenosynovitis in a 31-year-old male during the course of a severe bacteraemic illness caused by Haemophilus influenzae type b. The clinical presentation was similar to tenosynovitis caused by bacterial or viral agents. As the management of the H. influenzae tenosynovitis would differ from that due to other causes, the addition
Shivendu Bansal +2 more
openalex +5 more sources
NOD2/RICK-dependent β-defensin 2 regulation is protective for nontypeable Haemophilus influenzae-induced middle ear infection. [PDF]
, 2014 Middle ear infection, otitis media (OM), is clinically important due to the high incidence in children and its impact on the development of language and motor coordination.
Lee, Yoo Jin +5 more
core +14 more sources
Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules
BMC Infectious Diseases, 2021 Background Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a booster at the age of 16–18 months. The vaccination was simplified in 2013 to a 2 +
Eva Hong +6 more
doaj +1 more source
npj Vaccines, 2022 Since January 2018, mandatory vaccination against meningococci serogroup C has been implemented in France for children
Samy Taha +2 more
doaj +1 more source
Product review on the IMD serogroup B vaccine Bexsero®
Human Vaccines & Immunotherapeutics, 2022 Bexsero® is a multicomponent vaccine composed of four major proteins of Neisseria meningitidis: the fHbp, NHBA, NadA and PorA. This vaccine was licensed against invasive meningococcal disease (IMD) due to serogroup B isolates.
Ala-Eddine Deghmane, Muhamed-Kheir Taha
doaj +1 more source
Frontiers in Microbiology, 2023 BackgroundNon-typeable Haemophilus influenzae has become increasingly important as a causative agent of invasive diseases following vaccination against H. influenzae type b.
Esra Ekinci +13 more
doaj +1 more source
Haemophilus influenzae Carriage among Healthy Children in Portugal, 2015–2019
Microorganisms, 2022 Haemophilus influenzae is an important cause of mucosal and invasive infections and a common colonizer of the upper respiratory tract. As there are no recent data on H.
Maria Paula Bajanca-Lavado +6 more
doaj +1 more source
Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease
BMC Research Notes, 2020 Objective Few data are available on the association between SARS-CoV-2 and secondary bacterial infections. Such an association was described for flu and invasive meningococcal disease (IMD).
Muhamed-Kheir Taha, Ala-Eddine Deghmane
doaj +1 more source
Analysis of Haemophilus species in patients with respiratory tract infections in Yaoundé, Cameroon
International Journal of Infectious Diseases, 2020 Objectives: To identifyHaemophilus species and characterise the antimicrobial susceptibility of isolates from patients with respiratory tract infections (RTIs) in Cameroon.
Serges Tchatchouang +11 more
doaj +1 more source